A high-throughput method for fitting dose-response curves using Microsoft Excel

Jonathan D Parsons¹

¹Vertex Pharmaceuticals Inc., 130 Waverly Street, Cambridge, MA 02139, USA. jonathan_parsons@vrtx.com

Analytical Biochemistry

|November 28, 2006

Summary

No abstract available in PubMed .

Related Concept Videos

You might also read

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase.

Bioorganic & medicinal chemistry letters·2010

Same author

Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.

Journal of medicinal chemistry·2008

Same author

Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds.

Antimicrobial agents and chemotherapy·2006

Same author

In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class.

Antimicrobial agents and chemotherapy·2006

Same author

Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase.

Antimicrobial agents and chemotherapy·2004

Same author

Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.

Antimicrobial agents and chemotherapy·2003

Same journal

Lysozyme assay using a rationally designed GN4G2 substrate with coupled β-glucosidase reaction.

Analytical biochemistry·2026

Same journal

The long run: A tribute to Arthur Joseph Lawrence Cooper.

Analytical biochemistry·2026

Same journal

Evaluation of a method for affinity measurement using solution equilibrium titration with magnetic beads.

Analytical biochemistry·2026

Same journal

Metabolomics approach using UHPLC/QE-MS for the mechanism of He Xue Ming Mu tablets on non-proliferative diabetic retinopathy.

Analytical biochemistry·2026

Same journal

UniRES-GO: Unified residue-level early fusion of sequence and predicted structure for protein function prediction.

Analytical biochemistry·2026

Same journal

IgG detection by enzyme-linked mass spectrometric assay versus color, fluorescent, ECL in buffer and serum.

Analytical biochemistry·2026

See all related articles

Related Experiment Videos

A high-throughput method for fitting dose-response curves using Microsoft Excel

Related Concept Videos

Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase.

Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.

Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds.

In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class.

Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase.

Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.

Lysozyme assay using a rationally designed GN4G2 substrate with coupled β-glucosidase reaction.

The long run: A tribute to Arthur Joseph Lawrence Cooper.

Evaluation of a method for affinity measurement using solution equilibrium titration with magnetic beads.

Metabolomics approach using UHPLC/QE-MS for the mechanism of He Xue Ming Mu tablets on non-proliferative diabetic retinopathy.

UniRES-GO: Unified residue-level early fusion of sequence and predicted structure for protein function prediction.

IgG detection by enzyme-linked mass spectrometric assay versus color, fluorescent, ECL in buffer and serum.

Related Experiment Videos

A high-throughput method for fitting dose-response curves using Microsoft Excel

Related Concept Videos

Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase.

Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.

Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds.

In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class.

Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase.

Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.

Lysozyme assay using a rationally designed GN4G2 substrate with coupled β-glucosidase reaction.

The long run: A tribute to Arthur Joseph Lawrence Cooper.

Evaluation of a method for affinity measurement using solution equilibrium titration with magnetic beads.

Metabolomics approach using UHPLC/QE-MS for the mechanism of He Xue Ming Mu tablets on non-proliferative diabetic retinopathy.

UniRES-GO: Unified residue-level early fusion of sequence and predicted structure for protein function prediction.

IgG detection by enzyme-linked mass spectrometric assay versus color, fluorescent, ECL in buffer and serum.

Related Experiment Videos

A high-throughput method for fitting dose-response curves using Microsoft Excel

Related Concept Videos

Related Articles

Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase.

Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.

Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds.

In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class.

Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase.

Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.

Lysozyme assay using a rationally designed GN4G2 substrate with coupled β-glucosidase reaction.

The long run: A tribute to Arthur Joseph Lawrence Cooper.

Evaluation of a method for affinity measurement using solution equilibrium titration with magnetic beads.

Metabolomics approach using UHPLC/QE-MS for the mechanism of He Xue Ming Mu tablets on non-proliferative diabetic retinopathy.

UniRES-GO: Unified residue-level early fusion of sequence and predicted structure for protein function prediction.

IgG detection by enzyme-linked mass spectrometric assay versus color, fluorescent, ECL in buffer and serum.

Related Experiment Videos

A high-throughput method for fitting dose-response curves using Microsoft Excel

Related Concept Videos

Related Articles

Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase.

Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.

Dual targeting of GyrB and ParE by a novel aminobenzimidazole class of antibacterial compounds.

In vitro characterization of the antibacterial spectrum of novel bacterial type II topoisomerase inhibitors of the aminobenzimidazole class.

Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase.

Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.

Lysozyme assay using a rationally designed GN4G2 substrate with coupled β-glucosidase reaction.

The long run: A tribute to Arthur Joseph Lawrence Cooper.

Evaluation of a method for affinity measurement using solution equilibrium titration with magnetic beads.

Metabolomics approach using UHPLC/QE-MS for the mechanism of He Xue Ming Mu tablets on non-proliferative diabetic retinopathy.

UniRES-GO: Unified residue-level early fusion of sequence and predicted structure for protein function prediction.

IgG detection by enzyme-linked mass spectrometric assay versus color, fluorescent, ECL in buffer and serum.